Showing results (91-100 of 328) with videos related to
Sort By:
Pageof 33
Skin Pharmacology and Physiology|July 26, 2006
The pH of the skin surface and its impact on the barrier functionM-H Schmid-Wendtner, H C KortingArzneimittel-Forschung|April 1, 1989
Influence of various concentrations of cefotiam and ceftizoxime on the phagocytosis of gonococci by polymorphonuclear granulocytesH C Korting, R Seitz, W KrellerInternational Journal of Antimicrobial Agents|November 18, 2005
Current state of three-dimensional characterisation of antifungal targets and its use for molecular modelling in drug designE Ruge, H C Korting, C BorelliEuropean Journal of Clinical Pharmacology|January 1, 1992
0.25% prednicarbate cream and the corresponding vehicle induce less skin atrophy than 0.1% betamethasone-17-valerate cream and 0.05% clobetasol-17-propionate creamH C Korting, D Vieluf, M KerscherDermatologica|January 1, 1985
[Importance of the auxotyping of Neisseria gonorrhoeae for evaluating gonorrhea therapy studies]H C Korting, D Abeck, U NeubertDermatosen in Beruf Und Umwelt. Occupation and Environment|January 1, 1990
[Contact urticaria with transition to protein contact dermatitis in a cook with atopic diathesis]D Abeck, H C Korting, J RingMycoses|May 1, 1991
The detergent scrub method for quantitative determination of Malassezia furfur on chest and back skin: comparative evaluation of three different mediaH C Korting, S Loferer, N HammDie Pharmazie|June 16, 1999
Inhibitors of aspartic proteases in human diseases: molecular modeling comes of ageL Hoegl, H C Korting, G KlebeJournal of Molecular Medicine (Berlin, Germany)|March 1, 1996
The role of Candida albicans secreted aspartic proteinase in the development of candidosesL Hoegl, M Ollert, H C KortingPageof 33